Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Ventas, Inc. (VTR) Going to Burn These Hedge Funds?

With the third-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the fourth quarter. One of these stocks was Ventas, Inc. (NYSE:VTR).

Is Ventas, Inc. (NYSE:VTR) a sound investment right now? The number of long hedge fund bets shrunk by 2 in recent months.

Follow Ventas Inc (NYSE:VTR)
Trade (NYSE:VTR) Now!
Hospital Corporation hospital stocks CYH HCA THC UHS patient, corridor, doctor, bed, care, clinic

Spotmatik Ltd /

To most traders, hedge funds are viewed as unimportant, old investment tools of the past. While there are over 8000 funds trading today, Hedge fund experts at Insider Monkey hone in on the crème de la crème of this club, about 700 funds. These hedge fund managerspreside over the majority of the smart money’s total asset base, and by following their inimitable equity investments, Insider Monkey has formulated various investment strategies that have historically beaten the broader indices. Insider Monkey’s small-cap hedge fund strategy exceeded the S&P 500 index by 18 percentage points per year for a decade in their back tests.

Now, we’re going to analyze the new action surrounding Ventas, Inc. (NYSE:VTR).

What have hedge funds been doing with Ventas, Inc. (NYSE:VTR)?

At the end of the third quarter, a total of 22 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of -8% from the second quarter. With hedge funds’ positions undergoing their usual ebb and flow, there exists an “upper tier” of key hedge fund managers who were upping their holdings substantially.

According to hedge fund experts at Insider Monkey, Jim Simons’s Renaissance Technologies had the most valuable position in Ventas, Inc. (NYSE:VTR), worth close to $177.2 million, corresponding to 0.4% of its total 13F portfolio. The second largest stake is held by Jeffrey Furber of AEW Capital Management, with a $140.4 million position; 3.3% of its 13F portfolio is allocated to the company. Other peers that hold long positions comprise Cliff Asness’s AQR Capital Management, Phill Gross and Robert Atchinson’s Adage Capital Management and Greg Poole’s Echo Street Capital Management.

Seeing as Ventas, Inc. (NYSE:VTR) has witnessed falling interest from the smart money, it’s safe to say that there was a specific group of hedgies that slashed their positions entirely heading into Q4. It’s worth mentioning that Israel Englander’s Millennium Management dropped the largest position of all the hedgies watched by Insider Monkey, valued at an estimated $108.5 million in stock. Matthew Tewksbury’s fund, Stevens Capital Management, also dumped its stock, about $5 million worth. These bearish behaviors are important to note, as aggregate hedge fund interest was cut by 2 funds heading into Q4.

Let’s check out hedge fund activity in other stocks similar to Ventas, Inc. (NYSE:VTR). We will take a look at PACCAR Inc (NASDAQ:PCAR), Western Digital Corp. (NASDAQ:WDC), Twitter Inc (NYSE:TWTR), and Boston Properties, Inc. (NYSE:BXP). All of these stocks’ market caps are closest to VTR’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
PCAR 34 450787 7
WDC 51 2249022 2
TWTR 27 248317 -20
BXP 21 651123 -6

As you can see these stocks had an average of 33 hedge funds with bullish positions and the average amount invested in these stocks were $900 million.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!